US Patent Issued to ExoCoBio on April 21 for "Composition comprising iris-derived exosome as active ingredient" (South Korean Inventor)

ALEXANDRIA, Va., April 21 -- United States Patent no. 12,605,331, issued on April 21, was assigned to ExoCoBio Inc. (Cheongju-si, South Korea).

"Composition comprising iris-derived exosome as active ingredient" was invented by Byong Seung Cho (Anyang-si, South Korea).

According to the abstract* released by the U.S. Patent & Trademark Office: "A composition containing iris-derived exosomes as an active ingredient is provided for skin elasticity improvement, skin wrinkle reduction, skin regeneration, skin tone improvement, skin brightness improvement, skin whitening, anti-inflammation, wound healing and/or wound healing acceleration."

The patent was filed on Dec. 27, 2023, under Application No. 18/397,644.

*For further information, includ...